Register HERE!

Lung cancer remains atop the leader board as the primary cause of cancer deaths in women and men. This disease alone is responsible for almost a quarter of cancer-related mortalities. With screening being done in less than 10% of those at risk, better treatment strategies are urgently needed. This conference will provide evidence-based resources to address the challenges associated with the diagnosis and treatment of lung cancer, as well as evolving therapies.

Gastrointestinal cancers encompass a wide range of organ systems from the esophagus to the rectum including hepatobiliary and pancreas. The purpose of the GI session is to improve cancer care for patients throughout the regions.  This year, the conference will focus on patients while exploring the comprehensive aspects of cancer care such as nutrition, genetic testing, fertility preservation, pain management, and survivorship as well as reviewing some controversial management in rectal cancer and cholangiocarcinoma.

Target Audience

This conference is intended for medical, radiation, and surgical oncologists; primary care providers; nurse practitioners; physician assistants; nurses; respiratory therapists; fellows and residents caring for patients with thoracic and GI cancers.

Conference Objectives

At the conclusion of this conference, the participant should be better able to:

Thoracic Session

1. Discuss the current issues surrounding the use of electronic cigarettes and vaping
2. Discuss the current status of lung cancer screening (LCS) in non-smokers and the use of biomarkers in LCS patients
3. Develop a strategy for managing patients with sarcomatoid carcinoma (pleomorphic carcinoma)
4. Recognize the correlation between radiographic patterns and pathologic findings in thoracic malignancies
5. Review the current technologies and strategies available for the interventional pulmonologist and their role in the management of Non-Small Cell Lung Cancer (NSCLC)
6. Discuss the current role of radiation therapy in early-stage NSCLC
7. Discuss the role of adjuvant chemotherapy following Stereotactic Body Radiation Therapy (SBRT)
8. Develop a strategy for managing the endocrine, GI and rheumatologic complications of immunotherapy
9. Assess the data available regarding sub-lobar resections for NSCLC
10. Discuss strategies for predicting response to checkpoint inhibitors

GI Oncology

1. List the current immunotherapy and systemic therapy available for upper GI malignancy
2. Explain work up and management of cholangiocarcinoma
3. Identify the best treatment course for rectal cancer in terms of surgical and radiation options
4. Identify which patients will need a referral to genetics, reproductive medicine, and dietitian
5. Recognize the alternative to narcotics for pain management

Continuing Education Credits

PHYSICIANS
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Thoracic
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

GI
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Full Conference
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 15.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES
Nebraska Medicine is an approved provider of continuing nursing education by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Thoracic
8.25 Nursing Contact Hours Awarded
MW MSD Provider Approval # NE1019-5-680

You must be able to attend the entire presentation to receive contact hours. No partial credit will be awarded.

GI
7.25 Nursing Contact Hours Awarded
MW MSD Provider Approval # NE1019-5-681

Full Conference
15.50 Nursing Contact Hours Awarded
MW MSD Provider Approval # NE1019-5-679